| scholarly article | Q13442814 |
| P50 | author | Barbara J Turner | Q86825996 |
| P2093 | author name string | Mark Weiner | |
| Kathleen A Brady | |||
| P2860 | cites work | HIV, hepatitis B, and hepatitis C in the Code One trauma population | Q73457270 |
| Assessing drug use in the workplace: a comparison of self-report, urinalysis, and hair analysis | Q73557283 | ||
| Regular outpatient medical and drug abuse care and subsequent hospitalization of persons who use illicit drugs | Q73852002 | ||
| Description of a new hepatitis C risk assessment tool | Q81266555 | ||
| Knowledge of hepatitis among active drug injectors at a syringe exchange program | Q81889849 | ||
| Hepatitis C: cost of illness and considerations for the economic evaluation of antiviral therapies | Q22305832 | ||
| Diagnostic tests 4: likelihood ratios | Q24564390 | ||
| Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection | Q27860901 | ||
| Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention | Q28286743 | ||
| The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
| The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 | Q29620136 | ||
| Understanding delay to medical care for HIV infection: the long-term non-presenter | Q31977589 | ||
| Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 2001-02. | Q33993485 | ||
| Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings | Q34567572 | ||
| Seasonal variation in undiagnosed HIV infection on the general medicine and trauma services of two urban hospitals | Q34722926 | ||
| Screening for hepatitis C virus infection: a review of the evidence for the U.S. Preventive Services Task Force | Q35692299 | ||
| Risk factors for liver fibrosis progression in patients with chronic hepatitis C. | Q35750053 | ||
| Using an electronic medical record system to describe injury epidemiology and health care utilization at an inner-city hospital in Indiana | Q36132450 | ||
| Estimating numbers of injecting drug users in metropolitan areas for structural analyses of community vulnerability and for assessing relative degrees of service provision for injecting drug users | Q36272364 | ||
| A framework for management of hepatitis C in prisons | Q36479796 | ||
| Human immunodeficiency virus and hepatitis testing and prevalence among surgical patients in an urban university hospital | Q36692062 | ||
| Hepatitis C and progression of HIV disease | Q39607141 | ||
| Prevalence and risk factors associated with hepatitis C in ED patients. | Q39614623 | ||
| Hepatitis C seroprevalence and risk behaviors in patients attending sexually transmitted disease clinics | Q39639028 | ||
| Evaluation of screening criteria to identify persons with hepatitis C virus infection among sexually transmitted disease clinic clients: results from the San Diego Viral Hepatitis Integration Project | Q39645918 | ||
| Hepatitis C and hospital outcomes in patients admitted with alcohol-related problems | Q39733097 | ||
| Projecting future complications of chronic hepatitis C in the United States | Q40594872 | ||
| Evidence for a substantial role of sharing of injecting paraphernalia other than syringes/needles to the spread of hepatitis C among injecting drug users | Q42595031 | ||
| Identification and management of hepatitis C patients in primary care clinics | Q43049186 | ||
| Cross-sectional survey of the extent and indicators of hepatitis C virus infection in Houston Department of Health and Human Services' sexually transmitted disease clinics | Q43049451 | ||
| The association between knowledge of hepatitis C virus status and risk behaviors in injection drug users | Q44163628 | ||
| Prevalence of hepatitis A, hepatitis B, and HIV among hepatitis C-seropositive state hospital patients: results from Oregon State Hospital. | Q44631639 | ||
| Human immunodeficiency virus, hepatitis B, and hepatitis C seroprevalence in a Canadian trauma population | Q45427143 | ||
| Sensitivity and specificity of third-generation hepatitis C virus antibody detection assays: an analysis of the literature | Q45738097 | ||
| Racial differences in knowledge regarding hepatitis C virus infection | Q45740374 | ||
| Knowledge of and interest in hepatitis C treatment at a methadone clinic | Q48494486 | ||
| Gaining and losing health insurance: strengthening the evidence for effects on access to care and health outcomes | Q50133229 | ||
| Estimating the Prognosis of Hepatitis C Patients Infected by Transfusion in Canada between 1986 and 1990 | Q57695982 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 62-69 | |
| P577 | publication date | 2009-05-03 | |
| P1433 | published in | Journal of Infection | Q6295344 |
| P1476 | title | Undiagnosed hepatitis C on the general medicine and trauma services of two urban hospitals | |
| P478 | volume | 59 |
| Q41065322 | High priority for hepatitis C screening in safety net hospitals: Results from a prospective cohort of 4582 hospitalized baby boomers |
| Q36858883 | Hospital-Based Hepatitis C Screening of Baby Boomers in a Majority Hispanic South Texas Cohort: Successes and Barriers to Implementation |
| Q40922424 | Prevalence of blood-borne pathogens among 275 trauma patients : A prospective observational study |
| Q34524584 | Transitioning to highly effective therapies for the treatment of chronic hepatitis C virus infection: a policy statement and implementation guideline |
Search more.